Zdrowie i gospodarka · 29/03/2005

FDA Releases Guidances for Industry on Premarketing Risk Assessment and Pharmacovigilance Practices

The Food and Drug Administration (FDA) has released three new guidances to help the pharmaceutical industry manage risks associated with drug products, including biological drugs. These guidances cover premarket risk assessment, risk minimization action plans, and good pharmacovigilance practices.